The global pharmaceutical industry invested over $1.36 trillion in R&D in the decade from 2007 to 2016 and forecasts predict an annual investment of $181 billion by 2022. The US retains the highest share of R&D expenditure. In Europe, the UK has the highest share if exchange rate effects are excluded.
Figures are based on national trade association reported expenditure levels and may not reflect official statistics. “Others” countries include Australia, Ireland, Italy, Netherlands, Spain and Sweden. The chart uses exchange rates fixed at 2000 levels. If actual exchange rates are used, the relative shares of European countries change, with the UK declining in relative value.